Curious what ChatGPT could offer the rare disease community, columnist Candace Semien used the AI tool to prepare for a ...

Treatment with dapirolizumab pegol is better than a placebo at controlling disease activity in people with systemic lupus erythematosus (SLE), according to new results from a Phase 3 clinical trial.

Columnist Marisa Zeppieri welcomes the season of holiday food while offering tips to get people with lupus through any ...